While many of the leaders in the chemical and pharmaceutical industries rushed to invest in biotechnology over the past decade, W. R. Grace seemed to sit idle. But now that the multinationals have completed their first round of investments at top dollar and biotechnology novices have begun feeling the pain of long-term research financing, the sleeping giant seems to have awakened.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Rights and permissions
About this article
Cite this article
Grace, W. A Slow–Moving Giant Leaps into Bioresearch. Nat Biotechnol 1, 30–31 (1983). https://doi.org/10.1038/nbt0383-30
Issue Date:
DOI: https://doi.org/10.1038/nbt0383-30
This article is cited by
-
Human monoclonal antibodies: Methods of production and some aspects of their application in oncology
Medical Oncology and Tumor Pharmacotherapy (1984)